PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy-Reference-Cited by-同舟云学术

PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy

Published:2017-04-13 Issue:15 Volume:129 Page:2186-2197
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Asano Takeru¹,Meguri Yusuke¹,Yoshioka Takanori¹,Kishi Yuriko¹,Iwamoto Miki¹,Nakamura Makoto¹,Sando Yasuhisa¹,Yagita Hideo²,Koreth John³,Kim Haesook T.⁴^ORCID,Alyea Edwin P.³,Armand Philippe³,Cutler Corey S.³,Ho Vincent T.³,Antin Joseph H.³,Soiffer Robert J.³,Maeda Yoshinobu¹,Tanimoto Mitsune¹,Ritz Jerome³,Matsuoka Ken-ichi¹³

Affiliation:

1. Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

2. Department of Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan;

3. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and

4. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA

Abstract

Key Points IL-2 induces expression of PD-1 on Tregs, and PD-1 blockade promotes Treg differentiation and apoptosis. PD-1 regulates IL-2–induced Treg proliferation and prolongs Treg survival in murine models and in patients receiving low-dose IL-2 therapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/15/2186/1400571/blood741629.pdf

Reference59 articles.

1. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study;Bhatia;Blood,2007

2. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

3. Quality of life after allogeneic hematopoietic cell transplantation;Pidala;Blood,2009

4. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria;Arai;Blood,2011

5. Chronic graft-versus-host disease;Lee;Biol Blood Marrow Transplant,2003

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases;BioDrugs;2023-11-24

2. Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy;Cancer Treatment Reviews;2023-11

3. Memory regulatory T cells in pregnancy;Frontiers in Immunology;2023-10-26

4. Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer;British Journal of Cancer;2023-10-11

5. Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease;Frontiers in Hematology;2023-08-03